1) BTLA
B、T淋巴细胞弱化因子
2) B and T lymphocyte attenuator (BTLA)
B、T淋巴细胞弱化因子(BTLA)
3) B and T lymphocyte attenuator
B、T淋巴细胞衰减因子
1.
Objective To study and determine the inhibitory effect of in vivo-expressed soluble B and T lymphocyte attenuator (BTLA) on the growth of tumor, so to explore a new approach of tumor immunotherapy.
目的初步研究确定体内表达可溶性B、T淋巴细胞衰减因子(BTLA)对肿瘤生长的抑制作用,探索新的肿瘤免疫治疗途径。
4) B cell activating factor belonging to the TNF family(BAFF)
B淋巴细胞活化因子
1.
Objective:To screen for single-strand DNA aptamers specifically binding B cell activating factor belonging to the TNF family(BAFF) and to identify its affinity.
目的:进化筛选与B淋巴细胞活化因子(B cell activating factor be longing to the TNF family,BAFF)特异结合的单链DNA适体,鉴定其结合力。
2.
To screen single-strand DNA aptamers specifically binding B cell activating factor belonging to the TNF family(BAFF) and identify its affinity.
本研究目的是进化筛选与B淋巴细胞活化因子特异结合的单链DNA适体并鉴定其结合力。
5) lymphokine (T cell)
淋巴因子(T细胞)
6) B and T lymphocyte
B、T淋巴细胞衰减子
1.
AIM:To establish 293T cells expressing human BTLA gene,a novel attenuator for B and T lymphocyte.
目的:构建B、T淋巴细胞衰减子(BTLA)基因转染的细胞作为免疫原,并探讨该基因转染细胞在体外的生物学功能。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条